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It is well  documented that passively administered  antibody may suppress  (1-15) 
or enhance (10-18) a specific immune response. The possibility that antibody-mediated 
suppression involves the direct interaction of antigen with the combining sites of anti- 
body rests  largely  on  demonstrations  that  suppression  is  immunologically  specific 
(reviewed in ref.  19). Other findings, however, have been interpreted as indicating that 
suppression by antibody is mediated primarily  through a  direct effect on antibody- 
producing  cells  (20).  Interpretations  of  the  mechanisms  of antibody-mediated  en- 
hancement  of  the  immune  response  range  from  effects  attributable  to  nonspecific 
alterations in the physical state of antigen (19) to specific carrier effects, whereby anti- 
body to some determinants on a multideterminant antigen results in an increase in de- 
terminants  that function as carriers  (15).  The latter interpretation was proposed to 
explain our observations that passive antibody to foreign B blood group isoantigens in 
fowl suppresses the specific  anti-B response while enhancing the immune response to 
haptenic A isoantigens present on the same immunizing erythrocytes (14). According 
to this view, determinants coated with antibody are not capable of inducing antibody 
production to themselves but acquire the capacity to serve as carriers for noncoated 
determinants. Thus, we do not distinguish between two opposing effects of antibody 
(i.e.  suppression or enhancement)  but propose that antibody coating a  determinant 
blocks the immune response to that determinant and the net effect is determined,  at 
least in part, by the quantity of antibodies produced to noncoated determinants. 
The present studies were undertaken to elucidate further the effects of passive 
antibody on the  specificity  of the  immune  response  to multideterminant  iso- 
antigens.  One interpretation  of the results is that antibody-mediated enhance- 
ment and suppression  are effects which depend on the structural  relationships 
of coated  and noncoated  determinants.  These  structural  relationships  are  in- 
ferred by the finding that enhancement and suppression  are dependent  on the 
phenotype  of the  immunizing  erythrocyte.  On  the  basis  of these  findings  an 
interpretation  is offered for the discovery that antibody formation and major 
histocompatibility antigens may be controlled by dominant genes at the same 
locus (21). 
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Materials and Methods 
Animals.--Partially  inbred White Leghorn chickens (line G) were used as donors of erythro- 
cytes (RBC). 1 Recipients, which were from a closely related subline (line G-B1), were homo- 
zygous at the A  and B blood group loci (genotype A1/A 1, B1/BI). Donors possessed  foreign 
B and A or only foreign B isoantigens and were matched with the recipients with respect to 
isoantigens determined by other blood group loci. Breeding of the chickens is under our direc- 
tion. 
Production of Anti-B Antibody for In Vitro Coating of Donor RBC.--Hyperimmune anti-B 
antibody was produced in a recipient of B1/B 8 genotype by multiple weekly inoculations of 
washed RBC from a single donor. The specificity of the antibody was verified by testing RBC 
from birds of known blood group genotypes. The anti-B 2 antibody produced by this recipient 
did not cross-react with B 3 antigens. However, anti-B 2 antibody produced by a B 1/B1 recipient 
does cross-react with B3, presumably due to common B2 and B3 determinants. By use of a 
sensitive quantitative hemolytic assay employing rabbit antibody specific for chicken IgG and 
IgM,  2 we found that the anti-B ~ antibody used for coating donor RBC was predominantly of 
the IgG class and contained only trace amounts of IgM. 
Isoimmunization With Coated and Noncoated RBC.--To coat donor RBC with anti-B 2 anti- 
body, antiserum from pooled bleedings was added to an equal volume of washed and packed 
RBC and the mixture incubated at room temperature for 1 hr. Effects of the concentration of 
anti-B2 antibody used for coating were determined by adding undiluted or fivefold dilutions 
of antiserum to the RBC. The titer of the antiserum used for coating was such that only large 
clumps of cells were present after equal volumes of donor RBC and undiluted serum were 
mixed. Before inoculation of the coated RBC, unbound antibodies were removed by washing 
and centrifugation. Recipients, 6-8 wk of age, were given weekly intravenous inoculations of 
0.75 ml of a 25% suspension of RBC. They were bled (2.5 ml) for serum before each inoculation 
and i wk after the last. Each recipient group consisted of 7-10 animals. 
Serological Proeedures.--The titers of anti-A and/or anti-B hemagglutinins were determined 
in separate tests with RBC possessing  only the relevant antigens, i.e., A~, B2, or B3 • Sera 
were also titrated against donor RBC  to determine the combined effects of the antibodies 
produced (the "net immune response"). One drop of a 2% RBC suspension was added to 0.2 
ml of twofold dilutions of serum in 0.15 ~ saline and, after incubation, the degree of agglutina- 
tion scored macroscopically. Titers, which represent the last dilution showing detectable ag- 
glutination, were log-transformed for analysis. Where indicated, the specificity of the anti-B 
antibody was determined by absorption with appropriate RBC. 
RESULTS 
Effect of Passive Anti-B.~ Antibody on the Response to RBC Possessing B2 and 
B3 Antigens.--Two  groups  of chickens were given four weekly inoculations  of 
RBC  from a  donor of B2/B  3 genotype.  Group  1  received noncoated  RBC  and 
group  2  received RBC  coated  with  anti-B2  antibody.  Titrating  nonabsorbed 
sera  from  members  of  each  group  against  donor  RBC  revealed  that  coating 
caused  a  net enhancement  of the immune response.  Serum from the third  and 
fourth  bleedings was pooled for each  bird  to obtain  sufficient amounts  for ab- 
1 Abbreviations used in this paper: NRA, nonresponder antibody; RBC, erythrocytes. 
2 Bacon, L. D., L. W. Schierman, and R. A. McBride. Isoimmune hemolytic plaque-forming 
cells. I. The kinetics of appearance of 19S and 7S isoantibody releasing cells during a primary 
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sorption  studies.  The  results  are  summarized in  Table I.  Nonabsorbed  sera 
obtained from group 2 recipients were capable of agglutinating RBC possessing 
only B2  antigens.  Thus,  the  immune  response  to  all  determinants  of the  B2 
antigen was not abolished by passive anti-B2 antibody. The crucial question we 
wished to answer was: To which B2 determinants (i.e. coated or noncoated) was 
the immune response directed? This was answered by separately absorbing the 
sera with B2 and B3 antigens. In contrast to the results of absorption of group 1 
sera, absorption of group 2 sera with B3 antigens removed all reactivity against 
B2. This indicates that the anti-B2 hemagglutinins produced by group 2 birds 
were specific for noncoated determinants, i.e., those which B2 shares with B3. 
The titer of the antibodies produced against B~ determinants not shared with 
B2 was determined after absorption with B2 antigens. There was a significantly 
TABLE I 
Effect of Coating RB  C Possessing B 2 and B 3 Antigens with A nti-B 2 Antibody 
Number  Donor RBC  Recipient serum 
Group  of birds  treatment  absorbed with 
Hemagglutinin titers* in tests with RBC 
possessing  only 
B2  B3 
1  7  Noncoated 
2  7  Coated§ 
Nonabsorbed  210.0  (16-512)  512.0  (64-1024) 
B2  0  256.0  (32-512)5 
B~  70.7  (0-256)  0 
Nonabsorbed  70.7  (32-256)  1024.0 (512-2048) 
B2  0  760.9  (512-1024)  ~ 
B8  0  0 
* Geometric mean and (range) of antisera pooled from third and fourth bleedings. 
:~ Differences  in mean fiters statistically significant. P  < 0.02. 
§ The anti-B antibody was prepared in a bird of B1/B 3 genotype and coated only B2 de- 
terminants not shared with B 3 • 
enhanced  immune  response  to  unique  B3  determinants  among  birds  which 
received  coated  RBC  (Table  I).  Since  the  titers  of  anti-B2  hemagglutinins 
contained in nonabsorbed sera were lower in group 2 than in group 1, it appears 
that coating the RBC did not enhance the response to B3 determinants shared 
with B~. 
Effect of Passively Coating Some B  Determinants on the Immune Response to 
Other Determinants Controlled by the Same Gene.--The effect of coating unique 
B2 determinants on the response to determinants shared with B3 was further 
investigated.  Two groups of recipients were inoculated  with  RBC  possessing 
only foreign B2 antigens (donor genotype B2/B2). Group 1 received noncoated 
RBC while group 2 received RBC which had been coated with anti-B2 antibody. 
The anti-B2 antiserum used for coating the RBC was the same as the one used 
in the previous study. That the immune response among group 2 recipients to 836  PASSIVE  ANTIBODY  AND  THE  IMMUNE  RESPONSE 
both  coated and noncoated determinants was significantly suppressed can be 
seen from tb~ restdts in Fig. 1.  The anti-B.~ antib6dies produced by recipients 
of noncoated RBC cross-reacted extensively with RBC possessing only B 3 • This 
finding suggests that the shared determinants are potent immunogens.  We as- 
I0 
8 
e~ 
laJ 
i-  7 
l,-- 
z 
z  6 
I.-- 
._I 
5 
hl 
-r" 
~4 
(.D  o 
z 
©[]  ANTI-ANTI-  B3B  2  I  DONOR  RBC NOT COATED 
•  ANTI-  B  2  I  DONOR  RBC COATED  WITH 
II  ANTI-  B  3  ANTI-B  z ANTIBODY 
r 
6  .... 
L  "  ] 
rl 
I 
I  2  3  4  5  6 
WEEKS AFTER FIRST INOCULATION 
FIG. 1.  The immune response of birds of B1/B 1 genotype inoculated with RBC possessing 
foreign B 2 antigens. One group of birds received RBC coated in vitro with anti-B 2 antibody. 
Controls received noncoated RB C. Sera, obtained before each weekly  inoculation, were fitrated 
against RBC possessing only B2 and only B3 antigens. Each point represents the mean re- 
sponse of 10 birds and the vertical bars indicate the standard errors of the means. 
sume that among the recipients of coated RBC, the anti-B~ hemagglutinin titer 
reflects  the  degree of immune  response  to  B2  determinants  not  coated  with 
antibody. Absorption studies support this interpretation since all of the anti- 
bodies produced by recipients of coated RBC were removed by absorption with 
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It is apparent that the net effect of Passive anti-Bs antibody on the imnmne 
response  depends  on  the  antigenic  determinants  not  coated  With  antibody. 
Since in these studies noncoated determinants were products of the same genetic 
locus, it was of interest to examine the effects of the same antiserum, known to 
suppress  the immune response to noncoated B2 determinants,  on the immune 
response to noncoated determinants  controlled by another blood group locus. 
Two groups of recipients were inoculated with RBC possessing foreign As and 
B2  antigens  (donor  genotype  =  ASIA 2,  BS/BS).  Group  1  received  noncoated 
RBC  whereas  group 2  received  RBC  incubated,  before inoculation,  with  the 
anti-Bs  antiserum.  The findings  are presented  in Table  II. The  same passive 
anti-Bs  antibody  that  significantly  suppressed  the  immune  response  to  non- 
coated B2  determinants  significantly enhanced  the  response  to noncoated  As 
TABLE II 
Effect of Coating Some B2 Determinants with Antibody on the Immune Response to RBC 
Possessing Foreign B2 and A s Antigens 
Hemagglutinin titers  in tests with RBC possessing only 
Number  Donor  RBC 
Grouo  of birds  treatment 
B2  B3~  A2 
t  9  Noncoated  237.0  (128-256)§  69.1  (64-128)§  64.6  (16-256)§ 
2  9  Coated][  2.0  (0°8)§  1.9  (0-8)§  375.8  (256-1024)§ 
* Geometric mean and (range) after three weekly inoculations. 
The hemagglutinin  titers  determined  in tests  with RBC possessing B3 antigens  is as- 
sumed to measure the response to noncoated B 2 determinants. 
§ Differences in mean titers between groups 1 and 2 statistically  significant. P  <  0.001. 
I[ The anti-B2 antibody was prepared in a bird of B1/B 3 genotype and coated only B2 de- 
terminants  not shared with B 3 • 
determinants.  These results, in conjunction with our previous findings (14, 15), 
rule out the possibility that the anti-B2 antiserum  used in the present  studies 
possessed exclusive properties. 
Relationship of Suppression and Enhancement of the Immune Response to the 
Quantity of Passive A ntibody.--Since suppression or enhancement of the immune 
response may be a function of antigen-antibody ratio, we wished to determine 
the  relationship  of specific  suppression  and  enhancement  to  the  quantity  of 
passive antibody used to coat donor RBC. Four groups of recipients  received 
weekly inoculations of RBC possessing foreign A2 and Bs antigens (donor geno- 
type  =  ASIA s, BS/BS). One group received noncoated RBC and the remaining 
three groups received RBC incubated, before inoculation, with either undiluted, 
5-fold,  or  25-fold  dilutions  of  the  anti-B2  antiserum.  Significant  differences 
between  the  groups,  with  respect  to  the  mean  titers  of anti-As  and  anti-Bs 
antibodies, were evident after two inoculations. The relationship of the dilution 
of anti-B2 antiserum used for coating to the degree of anti-Bs suppression and 838  PASSIVE  ANTIBODY AND  TIIE  IMMUNE RESPONSE 
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FIG. 2.  The immune response of birds of B1/B 1 genotype inoculated with RBC possessing 
foreign B 2 and A~ antigens. Before inoculation, donor RBC were incubated with anti-B 2 anti- 
serum which was either undiluted or diluted 5-fold or 25-fold. Control birds received RBC not 
coated with antibody. Sera from each of the four groups of recipients were titrated against 
RBC possessing only B2 and only A2 antigens 1 wk after the second weekly inoculation. Each 
group contained l0 birds. Regression lines were fitted by the least squares method. 
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FIG. 3.  The regression of anfi-A antibody titer on the anfi-B antibody titer calculated 
from the data presented in Fig. 2. The slope of the regression line, fitted by the least squares 
method, is highly significant (P <  0.02) and the titers of anti-A and anfi-B antibodies have a 
high degree of negative correlation (r  =  --0.988). RAYMOND  A.  McBRIDE  AND  LOUIS  W.  SCItlERMAN  839 
anti-A2 enhancement is depicted in Fig. 2. With maximaf coating of B2 deter- 
minants, achieved with undiluted anti-B2 antiserum, there was nearly complete 
suppression  of  anti-B2  synthesis.  The  degree  of  anti-A2  enhancement  was 
greatest under these same conditions. Both effects were diminished as the anti- 
serum used for coating was diluted. Analysis of variance indicated a  linear re- 
lationship between the dilution of anti-B2 antiserum and the  titers of anti-B2 
and anti-A2 antibodies (P <  0.01  in both cases). 
The slope of the regression line drawn in Fig. 3 is also highly significant and 
reflects a  linear relationship between the log titers of anti-A and anti-B  anti- 
bodies. The degree of enhancement is inversely proportional to the degree of 
suppression since there is a statistically significant negative correlation between 
the anti-A and anti-B titers (r =  --0.998; P  <  0.02). 
DISCUSSION 
The  experiments  described  in  this  study  were  designed  to  determine  the 
effects of passive antibody  on  the  magnitude  and  specificity of the  immune 
response to isoantigens. Three types of isoantigenic determinants were studied: 
(a)  those  determined by the  same gene,  (b)  those  determined  by two  allelic 
genes, and (c) those determined by genes at different loci. The passive antibody, 
which was administered in combination with the RBC isoantigens, was identical 
in  all  experiments,  i.e.,  it  was  obtained  from a  single hyperimmunized bird. 
Since the recipients of the passively coated RBC were of the same genotype, 
we view the  observed differences in  response as dependent  on  the particular 
combination of coated and noncoated donor RBC determinants. Thus, in this 
system, overall suppression or enhancement of the immune response is not de- 
termined by the class of passive antibody. 
Antigens controlled by the B  blood group locus are multideterminant,  with 
specificities  shared  by  different  antigens.  By  analogy  with  the  biologically 
similar H-2 system of mice, it is likely that cross-reactive specificities controlled 
by different B  alleles are serologically identical (22). Thus, antibodies produced 
by recipients of B1/B 1 genotype after immunization with B2 antigens agglutinate 
RBC possessing B3 antigens  (Fig.  1). 3 However, the anti-B2 antiserum which 
we used for coating donor RBC was produced by a bird of BI/B ~ genotype and 
therefore  contained  antibodies  specific  only  for  those  B2  determinants  not 
shared with B~. 
Coating donor RBC with anti-B2 antibody results in suppression of the im- 
mune response to coated determinants  and may either enhance  (Table I)  or 
3  Although specific  B antigenic factors have not been identified, arbitrary symbols can be 
assigned. Accordingly, an anti-B2 antiserum may be considered to contain a population of 
antibodies specific  for determinants a, b, c, and d. If B3 antigens possess determinants c, d, e, 
and f, RBC possessing B 3 would be agglutinated by anti-B 2 antiserum on the basis of shared 
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suppress  (Fig.  1)  the  immune response  to noncoated determinants.  Enhance- 
ment occurs where donor RBC possess B3  determinants not  shared with B2, 
i.e., specificities determined by the B ~  gone. On the other hand, coating the same 
B2  specificities  results  in  suppression  of  the  immune  response  to  noncoated 
determinants if they are products of the same gone. At least two possibilities 
may account for suppression of the response to noncoated determinants.  First, 
there may be steric hindrance brought about by antibody coating determinants 
when the noncoated determinants are on the same molecule or on separate but 
structurally closely related molecules (23,  24).  Second,  since RBC from B2/B  2 
homozygotes presumably have twice as many determinants available for coating 
by anti-B2  as do  RBC  from B2/B  3 heterozygotes,  the  additional  quantity  of 
absorbed antibody may be sufficient to result in net suppression. The lack of in- 
formation on  the  biochemistry of the  B  antigens  of fowl precludes  firm con- 
clusions  as  to  the  validity of  the  first  possibility.  It is known  that  in  mice, 
different H-2 specificities determined by the same gone mav be present  on the 
same molecule (25)  and that hybrid molecules  exist in heterozygotes (26).  In 
this regard, an in vitro phenomenon interpretable as steric hindrance  mediated 
by antibody has been observed in the H-2 system (23). The results of the experi- 
ment  presented  in  Table  II provide evidence  against  the  second  possibility. 
The  same anti-B2  antiserum used to coat RBC  from B~/B  2 homozygotes sig- 
nificantly enhances  the  response to A2 determinants while suppressing the re- 
sponse to noi~coated B2 determinants present on the same RBC (hemagglutillin 
titer in  tests with  RBC  possessing only B3).  An  additional  argument against 
the second possibility is inferred by the data presented in Figs. 2 and 3.  With 
respect to B2 and A2 antigens, the degree of enhancement of the anti-A2 response 
is  greater  as  the  opportunity  for coating  B2  determinants  is  increased.  This 
relationship  is  in  accord  with  a  previous  prediction  that  a  maximal  anti-A 
response would occur when all foreign B  determinants are coated (14). A linear 
relationship between the degree of enhancement and suppression and quantity 
of passive antibody has  recently been  reported by others  (13).  We view the 
degree of anti-A enhancement as a  function  of the number of B  determinants 
converted to carrier by passive B antibody. Since the degree of anti-B suppres- 
sion is also determined bv the concentration of passive B  antibody (Fig. 2),  a 
negative  correlation  and  linear  relationship  between  the  anti-A  and  anti-B 
titers exists at a particular phase of the immune response (Fig. 3).  It is likely 
that the inverse relationship between the titers of anti-A and anti-B antibodies 
is a  reflection of the  total number of cells making isoantibodies and that this 
number is nearly constant among the four groups of recipients. On the basis of 
these considerations we assume that  enhancement of the immune response to 
noncoated B  determinants increases as the number of coated determinants  in- 
creases,  provided  the  coated  and  noncoated  specificities  are  determined  by 
alleles.  We therefore believe that the failure to observe enhancement of the im- RAYMOND  A.  McBRIDE  AND  LOUIS  W.  SCHIERMAN  841 
mune  response  to  noncoated  B2  determinants  (Fig.  1)  is  because  of  steric 
hindrance,  related to structural relationships, rather than effects attributable 
to the absorption of a greater quantity of anti-B2 antibody by RBC from B2/B  2 
homozygotes. 
The effects of passive antibody on the net immune response may differ even 
though the antibody is the same in each situation. By appropriate absorptions 
and  tests  with  single  antigens  we were  able  to  determine that  the  immune 
response to coated B2 determinants was suppressed and that the net enhance- 
ment observed was because of an augmented immune response to noncoated 
determinants.  The suggestion has been made,  with  regard to  the  two-deter- 
minant theory of antibody formation, that antibody coated determinants serve 
as carriers for noncoated determinants (15, 27). The present results suggest an 
additional requirement for immunogenicity, i.e., a  certain spatial relationship 
between coated and noncoated determinants. 
It is possible that this spatial relationship property has a bearing on the well- 
known  fact that  ABO  incompatibility protects  against  Rh  isoimmunization 
(28, 29). Perhaps the A, B, and Rh antigenic sites have a spatial relationship 
such  that  maternal  isoantibody combining with  A  and/or  B  suppresses,  by 
means of steric hindrance, the immune response to Rh. That significant steric 
effects because of antibody may exist between antigens determined by different 
genetic systems of mice (products of the TL system and the "D"  end of the 
H-2 system) has been shown in in vitro studies (24). Other studies, in addition 
to the present findings, suggest that in certain situations antibody to one or 
more determinants may suppress the immune respense to other determinants 
which are physically closely associated (30, 31). 
The  demonstration  that  antibody may  suppress  the  immune  response  to 
noncoated determinants, as well as block the response to coated determinants, 
may have relevance to genetic responder and nonresponder animals. The im- 
mune response to a variety of antigens behaves as a dominantly inherited trait 
apparently controlled by genes at the major histocompatibility lccus (21,  32). 
As a possible explanation of this phenomenon we propose that nonresponders 
possess an antibody which reacts with determinants of the antigen in such a 
manner that the immune response to other determinants is inhibited. This non- 
responder antibody (NRA) might arise (a) as a result of autoimmunization with 
antigens  determined  by  histocompatibility  genes  which  have  undergone 
somatic mutation or (b)  from prior exposure to environmental antigens pos- 
sessing the determinants. According to this interpretation responders would not 
have this antibody because it has specificity for a self antigen, i.e., the major 
histocompatibility antigen present on their cells. Although NRA may be present 
in the circulation, it is plausible that it corresponds to cell-bound receptors which 
may function in carrier recognition and enhancement of anti-hapten immune 
responses  (33-37).  It is of interest in  this regard that carrier-sensitized cells 842  PASSIVE  ANTIBODY  AND  THE  IMMUNE  RESPONSE 
have been shown to enhance anti-hapten immune responses in situations where 
passive antibody was ineffective (33-35, 37, 38). It remains to be seen whether 
"helper cells,"  like  serum  antibody in  our studies,  function only with those 
hapten-carrier systems in which optimal structural associations are presumed 
to exist. 
In addition to the mode of inheritance, findings which are consistent with our 
interpretation  of  the  responder-nonresponder  phenomenon  are:  (a)  the  re- 
sponder trait is, to a degree, quantitative, i.e., larger doses of antigen stimulate 
a response in "nonresponders" (39, 40). This feature suggests that with larger 
quantities of antigen the NRA is bound, and effectively removed, and the ex- 
cess quantity of free antigen is available for stimulation; (b) the nonresponder 
state is highly specific and may depend on single amino acid substitutions in the 
antigen (41, 42), a degree of specificity characteristic of antibodies; (c) the lack 
of  evidence for recombination between  "responder genes"  and  major histo- 
compatibility genes; and (d)  the high frequency of cells capable of responding 
to foreign major histocompatibility antigens (43), a finding which would allow 
for a sufficient quantity of NRA. 
The abrogation of the  nonresponder state after the induction of immuno- 
logical tolerance to responder histocompafibility antigens would support the 
proposed  interpretation.  The method  of  tolerance induction  would  have  to 
preclude the production of lymphoid cell chimerism. 
SUMMARY 
The isoimmune response of fowl inoculated with RBC coated with antibody 
was investigated. Anti-B antiserum from a single animal was used to coat dif- 
ferent donor type RBC. With each donor type RBC the immune response to 
the coated determinants is suppressed. Enhancement of the immune response 
to noncoated determinants occurs when they are products of an allelic gene or 
belong to a different blood group system. Coating some B antigen determinants 
suppresses the  response to noncoated determinants of the  same antigen, i.e., 
determinants which are products of the same B  gene. Varying the quantity of 
passive  antibody revealed that  the  degree of suppression  and  the  degree of 
enhancement are negatively correlated. 
These findings support the concept that antibody-coated determinants func- 
tion  as  carrier  for noncoated determinants,  provided  a  certain  physical  as- 
scciation exists between them. A further interpretation of these studies is that 
in certain situations an antibody to one antigen may interfere with events which 
lead to an immune response to a  different antigen. The possibility, that  the 
protection  afforded by  ABO  incompatibility  against  Rh  isoimmunization  is 
because of a similar phenomenon, is discussed. A hypothesis is presented which 
states that where the immune response to certain antigens behaves as a  domi- 
nantlv inherited trait, and is associated with histocompatibility type, the non- RAYMOND  A.  McBRIDE  AND  LOUIS  W.  SCI-IIERMAN  843 
responder  animals  possess  an  antibody  (perhaps  cell  bound)  which interferes 
with the  response  to determinants  for which it does not have specificity.  Re- 
sponders are assumed to lack this antibody because it has specificity for their 
major histocompatibility antigens. 
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